Results 161 to 170 of about 73,124 (298)

Somatic mutation analysis of mucin genes and pathways in idiopathic pulmonary fibrosis. [PDF]

Am J Respir Crit Care Med
Seo MK, Blumhagen R, Cho MH, Schwartz DA, Yun JH.   +4 more
europepmc   +1 more source

Alveolar epithelial cells in idiopathic pulmonary fibrosis display upregulation of TRAIL, DR4 and DR5 expression with simultaneous preferential over-expression of pro-apoptotic marker p53.

, 2014
Idiopathic pulmonary fibrosis (IPF) is a progressive, debilitating, and fatal lung disease of unknown aetiology with no current cure. The pathogenesis of IPF remains unclear but repeated alveolar epithelial cell (AEC) injuries and subsequent apoptosis ...
Akram, Khondoker M., Forsyth, Nicholas R., Spiteri, Monica A, Lomas, Nicola J.   +3 more
core  

Idiopathic Pulmonary Fibrosis update, comparing the Australasian Interstitial Lung Disease Registry to the Australian Idiopathic Pulmonary Fibrosis Registry

Internal Medicine Journal, EarlyView.
Abstract Background and aims Real‐world evaluation of clinical characteristics and treatment profile of patients with idiopathic pulmonary fibrosis (IPF) is needed to establish areas for improvement according to evidence‐based recommendations. This study evaluated the clinical characteristics and treatment profile of patients with IPF from the ...
Michelle Chee, Yet Hong Khor, Dan Jackson, Wendy Cooper, Jason D’Costa, Sally de Boer, Adrienne Edwards, Samantha Ellis, Eli Gabbay, Henry Gallagher, Ian Glaspole, Nicole Goh, Christopher Grainge, Peter Hopkins, Gregory Keir, Benjamin Kwan, John Mackintosh, Yuben Moodley, Irene Moore, Vidya Navaratnam, Chong Ong, Paul Reynolds, Karen Royals, Alan Teoh, Lauren Troy, Elizabeth Veitch, Margaret Wilsher, Jeremy Wrobel, Chris Zappala, Tamera Corte, Francis Thien, on behalf of the AILDR Steering Committee   +31 more
wiley   +1 more source

Prevalence and Recovery of Arrhythmia‐Induced Cardiomyopathy in Patients With Newly Diagnosed Heart Failure Using a Wearable Defibrillator: A Real‐World Cohort Study

Journal of Cardiovascular Electrophysiology, EarlyView.
This graphical abstract summarizes the study design and main findings in patients with newly diagnosed left ventricular systolic dysfunction and concomitant arrhythmia undergoing early rhythm control under wearable cardioverter‐defibrillator protection.
Joerg Yogarajah, Jana Dannebaum, Ahmed Halim, Jamschid Sedighi, Matthias Mensch, Malte Kuniss, Thomas Neumann, Andreas Rieth, Julia Treiber, Samuel Sossalla, Andreas Hain   +10 more
wiley   +1 more source

Regulated Cell Death in Idiopathic Pulmonary Fibrosis. [PDF]

FASEB J
Pan X, Yang L, Zhao M, Zhou Y, Xia C, Liu H, Wang Y, Lian H, Li B, Wang L, Yu G.   +10 more
europepmc   +1 more source

Single‐Cell Transcriptomics and Mendelian Randomization Analysis Reveal Key Genes in Atrial Fibrillation

Journal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Background Atrial fibrillation (AF) is one of the most common cardiac arrhythmias. It reduces quality of life and increases the risk of complications such as stroke. Although progress has been made in understanding its pathogenesis, the key cellular subtypes and therapeutic targets remain unclear. Methods We applied single‐cell transcriptomics
Xiangpeng Chen, Hongquan Chen, Shiguang Xu, Shumin Wang, Huishan Wang, Hao Meng   +5 more
wiley   +1 more source

Artificial intelligence chatbots and idiopathic pulmonary fibrosis: are they ready to inform patients? [PDF]

Rev Assoc Med Bras (1992)
Şenel MY, Ayan E, Çolak M, Çoban H, Erel F, Sarıoğlu N.   +5 more
europepmc   +1 more source

Critical care management of Interstitial Lung Disease with a focus on Idiopathic Pulmonary Fibrosis: Optimizing diagnosis and treatment

Introduction Exacerbations of interstitial lung disease (ILD), diffuse parenchymal lung diseases, or idiopathic pulmonary fibrosis can often lead to acute hypoxia, resulting in intensive care unit (ICU) admission.
Yusuke Hirao, Brent Matsuda, Joshua Hu, Shunsuke Kondo   +3 more
core   +1 more source

Risk of urinary tract infection with SGLT2 inhibitor initiation in patients with immune‐mediated inflammatory diseases and type 2 diabetes: A target trial emulation using a Japanese hospital‐based claims database

Journal of Diabetes Investigation, EarlyView.
In this target trial emulation of patients with immune‐mediated inflammatory diseases and type 2 diabetes, SGLT2 inhibitor initiation was not associated with a clear increase in UTI risk versus metformin, including across immunosuppressive therapy strata.
Hiroshi Tsushima, Nobuyuki Yajima, Takashi Nomiyama, Ryoko Sakai, Hisashi Noma, Akira Katagiri, Naoto Tamura   +6 more
wiley   +1 more source

Patient experiences of idiopathic pulmonary fibrosis (IPF) in China: a multicentre qualitative study. [PDF]

BMJ Open Respir Res
Yan B, Liu N, Zhou Y, Fang X, Zhang Y, Yuan B, Ji P, Zhan X, Ding Y, Xu X, Lu X, Gu X, Sexton V, Li F, Zhan S, Ji Y, Chu H.   +16 more
europepmc   +1 more source